Prognostic performance of multiple biomarkers in patients with non-ST-Segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non_ST-Elevation Acute Coronary Syndromes- Thrombolysis In Myocardial Infarction 36) (vol 63, pg 1644, 2014)

[摘要]

[发布日期] 2014-06-17